In part, the ability of dipyridamole to function as a phosphodiesterase (PDE) inhibitor and increase cyclic adenosine monophosphate (cAMP) levels sensitizes cancer cells to statin‐induced apoptosis. Here, ALDH7A1 is linked to cancer.